Clinical Trial Update: The Berkeley Orthokeratology Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating orthokeratology for correcting astigmatism and myopia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astigmatism
• Myopia

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Astigmatism, Myopia | Phase 3 | Status: COMPLETED